| Financial Year |
March 31 2023 |
| Monetary Funds |
3,263,924,307.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
40,153,650.00 |
| Accounts Receivable |
2,496,362,670.31 |
| Advances to Suppliers |
943,228,879.63 |
| Other Receivables |
34,692,992.48 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
13,960,129,444.55 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
265,123,246.92 |
| Total Current Assets |
23,886,695,204.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
954,654,541.69 |
| Investment Properties |
40,713,927.60 |
| Fixed Assetes |
2,598,166,063.76 |
| Under-construction Projects |
1,730,679,557.66 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
483,450,952.75 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
165,403,855.43 |
| Deferred Income Tax Assets |
242,342,479.66 |
| Other Non-Current Assets |
240,419,349.16 |
| Sub-Total of Non-Current Assets |
6,812,917,733.94 |
| Total Assets |
30,699,612,938.03 |
| Short-Term Loans |
1,090,703,388.88 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,051,563,533.80 |
| Accounts Payable |
4,457,254,032.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
99,205,414.34 |
| Taxes Payable |
206,323,095.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
41,092,167.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
172,447.85 |
| Other Current Liabilities |
127,136,993.12 |
| Sub-Total of Current Liabilities |
18,282,534,426.85 |
| Long-term Loans |
1,062,187.76 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
172,984,590.99 |
| Total Liabilities |
18,455,519,017.84 |
| Paid-In Capital(Or Share Stock) |
1,308,716,101.00 |
| Capital Surplus |
2,660,870,866.26 |
| Surplus Reserve |
767,662,950.48 |
| LESS:Treasury Stock |
55,560,810.60 |
| Undistributed Profits |
6,994,514,302.32 |
| Minority Stockholder's Interest |
565,555,991.69 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,678,537,928.50 |
| Owner's Equity（Stockholder's Equity） |
12,244,093,920.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
30,699,612,938.03 |
